Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 4
2011 1
2012 1
2013 5
2014 3
2015 3
2016 2
2017 2
2018 2
2019 1
2020 1
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents.
Umemoto S, Nakahashi-Ouchida R, Yuki Y, Kurokawa S, Machita T, Uchida Y, Mori H, Yamanoue T, Shibata T, Sawada SI, Ishige K, Hirano T, Fujihashi K, Akiyoshi K, Kurashima Y, Tokuhara D, Ernst PB, Suzuki M, Kiyono H. Umemoto S, et al. Among authors: kurokawa s. NPJ Vaccines. 2023 Jul 24;8(1):106. doi: 10.1038/s41541-023-00700-3. NPJ Vaccines. 2023. PMID: 37488116 Free PMC article.
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Yuki Y, Nojima M, Kashima K, Sugiura K, Maruyama S, Kurokawa S, Yamanoue T, Nakahashi-Ouchida R, Nakajima H, Hiraizumi T, Kohno H, Goto E, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: kurokawa s. Vaccine. 2022 May 26;40(24):3372-3379. doi: 10.1016/j.vaccine.2022.04.051. Epub 2022 Apr 26. Vaccine. 2022. PMID: 35484039 Free article. Clinical Trial.
Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus.
Sasou A, Yuki Y, Kurokawa S, Sato S, Goda Y, Uchida M, Matsumoto N, Sagara H, Watanabe Y, Kuroda M, Sakon N, Sugiura K, Nakahashi-Ouchida R, Ushijima H, Fujihashi K, Kiyono H. Sasou A, et al. Among authors: kurokawa s. Front Plant Sci. 2021 Feb 23;12:639953. doi: 10.3389/fpls.2021.639953. eCollection 2021. Front Plant Sci. 2021. PMID: 33868338 Free PMC article.
A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids.
Takahashi Y, Sato S, Kurashima Y, Yamamoto T, Kurokawa S, Yuki Y, Takemura N, Uematsu S, Lai CY, Otsu M, Matsuno H, Osawa H, Mizushima T, Nishimura J, Hayashi M, Yamaguchi T, Kiyono H. Takahashi Y, et al. Among authors: kurokawa s. Stem Cell Reports. 2018 Jan 9;10(1):314-328. doi: 10.1016/j.stemcr.2017.11.004. Epub 2017 Dec 7. Stem Cell Reports. 2018. PMID: 29233552 Free PMC article.
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.
Yuki Y, Uchida Y, Sawada SI, Nakahashi-Ouchida R, Sugiura K, Mori H, Yamanoue T, Machita T, Honma A, Kurokawa S, Mukerji R, Briles DE, Akiyoshi K, Kiyono H. Yuki Y, et al. Among authors: kurokawa s. Mol Pharm. 2021 Apr 5;18(4):1582-1592. doi: 10.1021/acs.molpharmaceut.0c01003. Epub 2021 Feb 23. Mol Pharm. 2021. PMID: 33621107 Free article.
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.
Tokuhara D, Álvarez B, Mejima M, Hiroiwa T, Takahashi Y, Kurokawa S, Kuroda M, Oyama M, Kozuka-Hata H, Nochi T, Sagara H, Aladin F, Marcotte H, Frenken LG, Iturriza-Gómara M, Kiyono H, Hammarström L, Yuki Y. Tokuhara D, et al. Among authors: kurokawa s. J Clin Invest. 2013 Sep;123(9):3829-38. doi: 10.1172/JCI70266. Epub 2013 Aug 8. J Clin Invest. 2013. PMID: 23925294 Free PMC article.
32 results